Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Current and future treatment of amyloid diseases.

Ankarcrona M, Winblad B, Monteiro C, Fearns C, Powers ET, Johansson J, Westermark GT, Presto J, Ericzon BG, Kelly JW.

J Intern Med. 2016 Aug;280(2):177-202. doi: 10.1111/joim.12506. Epub 2016 May 10.

PMID:
27165517
2.

AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.

Penchala SC, Connelly S, Wang Y, Park MS, Zhao L, Baranczak A, Rappley I, Vogel H, Liedtke M, Witteles RM, Powers ET, Reixach N, Chan WK, Wilson IA, Kelly JW, Graef IA, Alhamadsheh MM.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9992-7. doi: 10.1073/pnas.1300761110. Epub 2013 May 28.

3.

Guideline of transthyretin-related hereditary amyloidosis for clinicians.

Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon BG, Ikeda S, Lewis WD, Obici L, Planté-Bordeneuve V, Rapezzi C, Said G, Salvi F.

Orphanet J Rare Dis. 2013 Feb 20;8:31. doi: 10.1186/1750-1172-8-31. Review.

4.

Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy.

Wixner J, Karling P, Rydh A, Hörnsten R, Wiklund U, Anan I, Suhr OB.

Neurogastroenterol Motil. 2012 Dec;24(12):1111-e568. doi: 10.1111/j.1365-2982.2012.01991.x. Epub 2012 Aug 16.

5.

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.

Bulawa CE, Connelly S, Devit M, Wang L, Weigel C, Fleming JA, Packman J, Powers ET, Wiseman RL, Foss TR, Wilson IA, Kelly JW, Labaudinière R.

Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9629-34. doi: 10.1073/pnas.1121005109. Epub 2012 May 29.

6.

The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

Johnson SM, Connelly S, Fearns C, Powers ET, Kelly JW.

J Mol Biol. 2012 Aug 10;421(2-3):185-203. doi: 10.1016/j.jmb.2011.12.060. Epub 2012 Jan 5. Review.

7.

Patterns of neuropathy and autonomic failure in patients with amyloidosis.

Wang AK, Fealey RD, Gehrking TL, Low PA.

Mayo Clin Proc. 2008 Nov;83(11):1226-30. doi: 10.4065/83.11.1226.

8.

Supplemental Content

Support Center